Teleflex reports Q3 adjusted EPS $3.67, consensus $3.38

Reports Q3 revenue $913M, consensus $892.78M. “We executed well in the third quarter, delivering adjusted operating margin and earnings per share above our expectations and revenue at the midpoint of our guidance range, despite lower than expected order rates in our intra-aortic balloon pump portfolio,” said Liam Kelly, Teleflex’s (TFX) Chairman, President and Chief Executive Officer. “Revenue from the acquired Vascular Intervention business modestly exceeded our guidance of $99 million and integration activities have remained on track. We have continued to make steady progress advancing our value creation strategy across the business including through the separation of Teleflex into two companies, RemainCo and NewCo. We continue to actively advance the process of a potential sale of NewCo, which has become our primary focus. We are confident in our ability to execute on our strategy and drive shareholder value creation.